Neutral dimeric copper–sparfloxacin conjugate having butterfly motif with antiproliferative effects against hormone independent BT20 breast cancer cell line

[1]  Sanjeev Banerjee,et al.  Synthesis, molecular characterization, and biological activity of novel synthetic derivatives of chromen-4-one in human cancer cells. , 2006, Journal of medicinal chemistry.

[2]  S. H. Cardoso,et al.  Fluoroquinolones: an important class of antibiotics against tuberculosis. , 2006, Current medicinal chemistry.

[3]  S. Das,et al.  Evaluation of Antiproliferative Activity of Enoxacin on a Human Breast Cancer Cell Line , 2005 .

[4]  Roman Jerala,et al.  Mixed-valence Cu(II)/Cu(I) complex of quinolone ciprofloxacin isolated by a hydrothermal reaction in the presence of L-histidine: comparison of biological activities of various copper-ciprofloxacin compounds. , 2005, Journal of inorganic biochemistry.

[5]  E. Liu,et al.  Her-2/neu and Topoisomerase iiα in Breast Cancer , 2003, Breast Cancer Research and Treatment.

[6]  M. Palumbo,et al.  The quinolone family: from antibacterial to anticancer agents. , 2003, Current medicinal chemistry. Anti-cancer agents.

[7]  I. Turel,et al.  A novel copper(II) complex with 1,10-phenanthroline and ciprofloxacin. , 2003, Acta crystallographica. Section C, Crystal structure communications.

[8]  A. Powell,et al.  Antimycobacterial activity of mixed-ligand copper quinolone complexes , 2003 .

[9]  P. Livne,et al.  Human DNA topoisomerase‐IIα expression as a prognostic factor for transitional cell carcinoma of the urinary bladder , 2003, BJU international.

[10]  I. Turel,et al.  Crystal Structure of Ciprofloxacin Hydrochloride 1.34-Hydrate , 2003, Analytical sciences : the international journal of the Japan Society for Analytical Chemistry.

[11]  I. Turel.  The interactions of metal ions with quinolone antibacterial agents , 2002 .

[12]  M. Villa,et al.  Complexes of Ni(II) and Cu(II) with ofloxacin. Crystal structure of a new Cu(II) ofloxacin complex. , 2001, Journal of inorganic biochemistry.

[13]  Jerome J. Schentag.  Sparfloxacin: a review. , 2000, Clinical therapeutics.

[14]  F. Sarkar,et al.  Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

[15]  J. Holden,et al.  Elevations of DNA topoisomerase I in transitional cell carcinoma of the urinary bladder: correlation with DNA topoisomerase II-alpha and p53 expression. , 1999, Human pathology.

[16]  T. Inagaki,et al.  The cytotoxic effects of fleroxacin and ciprofloxacin on transitional cell carcinoma in Vitro , 1997, Cancer.

[17]  M. Yamakuchi,et al.  New quinolones, ofloxacin and levofloxacin, inhibit telomerase activity in transitional cell carcinoma cell lines. , 1997, Cancer letters.

[18]  K. Drlica,et al.  DNA gyrase, topoisomerase IV, and the 4-quinolones , 1997, Microbiology and molecular biology reviews : MMBR.

[19]  J. Latorre,et al.  Potentiometric and spectroscopic studies of transition-metal ions complexes with a quinolone derivative (cinoxacin). Crystal structures of new Cu(II) and Ni(II) cinoxacin complexes , 1997 .

[20]  J. Kononen,et al.  Expression of topoisomerase IIalpha is associated with rapid cell proliferation, aneuploidy, and c-erbB2 overexpression in breast cancer. , 1996, The American journal of pathology.

[21]  T. Hambley,et al.  Copper(II) complexes of the fluoroquinolone antimicrobial ciprofloxacin. Synthesis, X-ray structural characterization, and potentiometric study. , 1996, Journal of inorganic biochemistry.

[22]  T. Seay,et al.  Inhibition of human transitional cell carcinoma in vitro proliferation by fluoroquinolone antibiotics. , 1996, The Journal of urology.

[23]  L. Martínez-Aguilera,et al.  Some mixed-ligand complexes of copper(II) with drugs of the quinolone family and (NN) donors. Crystal structure of [Cu(phen)(Cnx)(H2O)]NO3 · H2O , 1993 .

[24]  C. Truffot-Pernot,et al.  Powerful bactericidal activity of sparfloxacin (AT-4140) against Mycobacterium tuberculosis in mice , 1993, Antimicrobial Agents and Chemotherapy.

[25]  F. Zunino,et al.  Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development. , 1992, Biochimica et biophysica acta.

[26]  W. Earnshaw,et al.  Topoisomerase II: A specific marker for cell proliferation , 1986, The Journal of cell biology.